tbuckley/cabot-search huggingface dataset:
2103P Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head &amp; neck (H&amp;N) cancer
Authors: D. Osei-Fofie, M. Dimitriu, G. Landers, J. Wetter, P.A. Kraus, A. Lategan, S. Sonis
Journal: Annals of Oncology (2023)
2106P Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer
Authors: A. Body, M.W. Donoghoe, E.S. Ahern, L. Lal, P. Downie, M.F. Leahy, N. Fuentes-Bolanos, A. Anazodo, B. Padhye, N. Hamad, C.E. Wakefield, E. Segelov
Journal: Annals of Oncology (2023)
2104P Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Authors: K. Johnson, B. Stoffel, M. Schwitter, S. Hayoz, A. Rojas Mora, P. Richter, A. Fischer Maranta, T. El Saadany, U. Hasler-Strub, R.A.F. von Moos, A. Patzen, M.T. Mark, G. Roberts, R. Cathomas
Journal: Annals of Oncology (2023)
2107P Thromboprophylaxis with intermediate or prophylactic doses of LMWHs in ambulatory cancer patients
Authors: N.G. Tsoukalas, A.N. Christopoulou, E. Timotheadou, A. Koumarianou, A. Ardavanis, I. Athanasiadis, M. Demiri, A. Bokas, G.F. Samelis, S. Peroukidis, G. Papatsimpas, C. Andreadis, C. Kalofonos, A. Psyrri, N. Kapodistrias, P. Papakostas, G. Pentheroudakis, G. Aravantinos, P. Papakotoulas, I. Boukovinas
Journal: Annals of Oncology (2023)
2109P Vitamin A, D and E levels in patients with solid tumors undergoing palliative systemic cancer treatment
Authors: J.M. Berger, C. Englisch, L. Gottmann, M. Korpan, M. Kleinberger, A.M. Starzer, R. Marculescu, M. Preusser, A.S. Berghoff
Journal: Annals of Oncology (2023)
2057P Prevalence of frailty in long-term prostate cancer survivors after radical prostatectomy and its association with quality of life and emotional health
Authors: V.H. Meissner, K. Imhof, M. Jahnen, L. Lunger, A. Dinkel, S. Schiele, J.E. Gschwend, K. Herkommer
Journal: Annals of Oncology (2023)
2053P Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Authors: K. Borges, K.M. Penalber, S.O. Queiroz, B.V.R.E. Almeida, G.M. Alameida, C. Borges Junior, S.S. Alvarenga, P. Soares, T. Rodrigues
Journal: Annals of Oncology (2023)
2052P Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Authors: C. Oliveira, E. Couto, A. Marques, F.M. Ferreira Pereira, J.A.L.D.A. Cunha, M. Peixoto, C. Honrado Martins, D.S. Freitas, J.R. Rodrigues
Journal: Annals of Oncology (2023)
2049P Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Authors: G.F. Moreira, I. Borchardt, F.C. Dias, F.T. Taveira, L.D.O. Pina, W.M. Rocha, T.C. Montella, A.C. de Melo, C.G.M. Ferreira
Journal: Annals of Oncology (2023)
2051P E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Authors: P.E. Rioja Viera, R.E. Ruiz, J.M. Araujo, J.G. Macetas, S. Acevedo, T. Guevara, M.Q. Puente, F. Young, P. Montenegro
Journal: Annals of Oncology (2023)
2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Authors: C. Vercueil, R. Varnier, R. Seban, L. CIaptacz, J. Pavillet, C. Fraisse, T. Darbas, S. Abdallahoui, D. Cox, S. Martin, P. Trensz, J.E. Kurtz, J. Gantzer, S. Ame, C. Bouleuc, G. Chvetzoff, L. Eberst
Journal: Annals of Oncology (2023)
2044P Bloodstream infections (BSI) in cancer patients: Epidemiology, antibiotic therapy and risk factors related to mortality
Authors: C. López Jiménez, R. Martín Lozano, R. Jiménez Rodríguez, I. Gonzalez Caraballo, M. Benavente, A. Gutierrez Ortiz, D.S. Juliao Caamaño, N. Gutierrez Alonso, J. Soto Alsar, M. Bringas Beranek, M. Palma, M.A. Cañete Muñoz, L. Biscari, P. Martin-Nieto, B.I. Morón, V.C. Tirado Anula, M.T. De Toro Carmena, M. Arregui Valles, P. Gijón Vidaurreta
Journal: Annals of Oncology (2023)
2055P Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU
Authors: F.J. Ros Montana, N. Saoudi Gonzalez, S.A. Bueno Salazar, C. Diaz, S. Vega, A. Albasanz, J. Aguilar Company, P. Gallardo, P. Gomez Pardo, M. Roca Herrera, S. Eremiev, P. Mascaro, P.B. Buch, J.G. Yaringaño, C. Ortiz, J. Carles Galceran, I. Ruiz, R. Ferrer, M.E. Elez Fernandez
Journal: Annals of Oncology (2023)
2056P Hospitalization, reconsultations and mortality in the field of oncological emergencies: Who is at higher risk?
Authors: E.M. Martínez Madrid, M. Sanchez Canovas, A. Sanchez Saura, S. Montenegro Luis, M.A. Ivars, N. Blaya Boluda, M.E. Guirao García, C. Moreno Barba, R. Pérez Costa, F. Ayala de la Pena
Journal: Annals of Oncology (2023)
2064P Hospitalisation of patients with cancer: Identifying points for improvement in patient care in a university hospital in Spain
Authors: S. Roa, I. Hernández de Córdoba Sánchez, M. Morales Parga, I. Pizarro Sanz, J.M. Vincente Fraile, A. Sánchez, M. Merino Salvador, M. Moyano-Sereno, E. Casado Sáenz, C. Gomez Raposo
Journal: Annals of Oncology (2023)
2065P Communication on the first medical oncology appointment: What do cancer patients want?
Authors: R.S. Vicente, M. Barbosa, R.M. Ferreira, R.R. Freitas, S. Parada Prada, T.S. Martins, T.M. Caleça, A. Duarte Mendes, M.M. Vitorino, C. Santos, D. Alpuim Costa
Journal: Annals of Oncology (2023)
2080P Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Authors: O. Rohr, S. Priou, G. Lamé, G. Chatelier, S. Babai, S. Gallien, R. Flicoteaux, C. Tournigand, E. Kempf
Journal: Annals of Oncology (2023)
2061P Network analysis of comprehensive concerns in patients with cancer: Differences between the sexes
Authors: K. Yamamoto, Y. Tanabe Hashimoto, K. Nonogaki, H. Kono, E. Toda, H. Okumura, H. Ozaki, M. Kuno, S. Watanabe, K. Takemura, T. Yamanaka, R. Kizawa, T. Yamaguchi, K. Tanaka, Y. Kobayashi, T. Ogura, N. Tamura-Hatano, H. Kawabata, K. Suyama, Y. Miura
Journal: Annals of Oncology (2023)
2077P A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Authors: T. Didangelos, E. Chamalidou, E. Karlafti, Z. Kontoninas, C. Savopoulos
Journal: Annals of Oncology (2023)
2082P TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Authors: M. Filetti, D. Trapani, P. Lombardi, S. Zeb Khan, J.B. Bezuidenhout, A. Carnevale Schianca, Y. Coskun, B. Habibe, A. Seeber, A. Petrillo, F.U. Seid, C.G. Lengyel, S. Hussain, S.J. Nidhamalddin, E. Elfaham, A.O. Odhiambo, S.C. Altuna, G. Daniele, G. Porzio, R. Giusti
Journal: Annals of Oncology (2023)
2083P Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Authors: R. Martín Lozano, M. Palma, A. Rodriguez Gonzalez, J. Rubio Perez, I. Fernandez Perez, I. Garcia Escobar, S. Garcia Adrian, J.A. Santiago Crespo, C. Diaz PedRoche, M.T. Antonio Rebollo, M.J. Ortiz Morales, M.E. Guirao García, P. Martinez del Prado, M. Garcia De Herreros, R. Porta-Balanya, M. Covela, L. Ortega Morán, E. Martinez de Castro, P. Pérez Segura, A.J. Munoz Martin
Journal: Annals of Oncology (2023)
2062P The psychological distress (PsyD) evaluation in pancreatic cancer (PC) patients (pts): A mono-institutional analysis
Authors: M. Bensi, D. Belella, C. Bagalà, D. Barone, M. Chiaravalli, E. Gurreri, F. Veccia, A. Spring, G. Trovato, A. Di Bello, V. Beccia, D. Ferrare, S. Perazzo, A. Ceccarelli, G. Messina, G. Quero, S. Alfieri, D.P.R. Chieffo, G. Tortora, L. Salvatore
Journal: Annals of Oncology (2023)
2079P Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Authors: M.D.C. Beato Zambrano, A. Lemaire, V. Montesarchio, J-M. Sabate, J. Serna i Mont-Ros, R. Namane, S. Martín Baccarelli, F. Rico-Villademoros, M. Cobo
Journal: Annals of Oncology (2023)
2070P Assessment of healthy lifestyle habits in breast cancer patients
Authors: J.C. Sanchez, B. Cantos, M. Mendez Garcia, B. Nunez Garcia, M. Blanco Clemente, C. Parejo, M. Campos, B. Rodriguez Morilla, P.F. Almaida Pagan, S.C. González González, C. Traseira Puchol, M. Martinez Cutillas, R. Aguado, Y. Garitaonaindía Díaz, A. González Sánchez, D.I. Ruiz de Domingo, M.M. Sánchez del Corral, I. Redondo, M. Torrente, M. Provencio Pulla
Journal: Annals of Oncology (2023)
2063P Lifestyle changes as cancer treatment: It is time to get specific with our patients
Authors: A.I. Martin Quesada, A. Herrero Márquez, M. Gutierrez Gordo, P. Rodriguez, L. Herrera Gorrìn, A. Padilla, A. Rosa Díaz, C. Dorta Pérez, I. Nunez Hernandez, N.D. Pérez-Rodríguez, M. Pulido Torrente, M.L. Soriano Tabares, C. Hernández Pérez, M. Morales-Gonzalez, L. Pérez Mendez, A. Cardena
Journal: Annals of Oncology (2023)
2075P MW05, a novel, long-acting recombinant human serum albumin/human granulocyte-colony stimulating factor(I) fusion protein for the management of chemotherapy-induced neutropenia: Results of a phase III trial
Authors: X. Hu, B. Wang, X. Chen, H. Li, J. Sun, X. Jia, T. Sun, Y. Yao, J. Wang, J. Li, X. Wang, X. Wang, C. Geng, Y. Ren, L. Yang, J. Jia, Y. Chen, Z. Li, P. Wang
Journal: Annals of Oncology (2023)
1270P Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes
Authors: R. Zhong, H. Liang, Y. Jiang, Y. Lin, W. Fu, Y. Xiong, S. Xiong, R. Wang, Z. Ye, X. Li, J. Li, F. Li, H. Wang, Y. Xiang, Z. Yu, S. Zhan, P. Chen, X. Zheng, W. Liang, J. He
Journal: Annals of Oncology (2023)
1264MO IMpower010: Exploratory analysis of disease-free survival (DFS) by TGFβ cancer-associated fibroblast (CAF) gene signature expression in patients (pts) with resected NSCLC treated with atezolizumab (atezo) or best supportive care (BSC)
Authors: N.K. Altorki, M. Reck, H. Wakelee, E. Felip, E. Vallieres, R. Liersch, S. Oizumi, H. Tanaka, S. Novello, S. McCune, H. Li, L. Molinero, S. Müller, E. Bennett, B.J. Gitlitz, V.A. McNally, M. Ballinger, B. Nabet, M.K. Srivastava, C. Zhou
Journal: Annals of Oncology (2023)
1193P Evaluation of treatment appropriateness in patients submitted to surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs)
Authors: A. Battistella, V. Andreasi, F. Muffatti, F. Fermi, G. Balzano, S. Crippa, S. Partelli, M. Falconi
Journal: Annals of Oncology (2023)
1278P ORIGEN: Multicenter study on the prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain
Authors: E. Nadal, C. Alvarez Fernandez, H. Arasanz, S. Peralta Muñoz, M. Lázaro Quintela, C. Teixido, V. Calvo de Juan, R.M. Alvarez, J. Baena Espinar, J. Valdivia-Bautista, E. Arriola, R. Lastra, R. Bernabe Caro, C. Camacho, A. Blasco Cordellat, B. Massuti Sureda, M. Campayo Guillaumes, M. Cobo Dols, T. Garcia Manrique, G.J. Marquez
Journal: Annals of Oncology (2023)
1292MO A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A
Authors: R. Ko, A. Mouri, A. Kisohara, R. Morita, T. Nakagawa, T. Makiguchi, K. Isobe, N. Ishikawa, T. Kondo, M. Akiyama, A. Bessho, R. Honda, K. Yoshimura, H. Kagamu, S. Kato, K. Kobayashi, K. Kaira
Journal: Annals of Oncology (2023)
1282P Concordance of PD-L1 expression between biopsy and matched surgical specimen in early-stage non-small cell lung cancer: LC-SCRUM-Advantage/MRD
Authors: Y. Zenke, K. Yoh, S. Kitagawa, J. Samejima, T. Kasugai, H. Daga, K. Kunimasa, T. Kato, I. Nakachi, A. Osoegawa, S. Miyamoto, H. Izumi, T. Sakai, S. Umemura, E. Sugiyama, K. Murai, S. Matsumoto, M. Tsuboi, K. Goto
Journal: Annals of Oncology (2023)
1280P Comprehensive characterization of human lung squamous cell carcinoma identifies high TFRC expression as a mark of poorly immunogenic tumours
Authors: M. Gutiérrez Pérez, J. Ramos Paradas, D. Gomez Sanchez, R. Garcia Lujan, J. Zugazagoitia, N. Carrizo, A.B. Enguita, E. Conde Gallego, E.M. Garrido-Martin, A.C. Ucero, L. Paz-Ares
Journal: Annals of Oncology (2023)
1202P Final analysis of TENEC trial: A phase II trial of temozolomide (TMZ) as second-line treatment for advanced neuroendocrine carcinomas (NEC) in patients (pts) with a poor performance status (PS)
Authors: C. von Arx, L. Cannella, A.L. Marretta, A. Bracigliano, F. Tatangelo, O. Clemente, D. Iervolino, V. Granata, C. Mocerino, R. Modica, A. Pizzolorusso, A. Bianco, F. Picozzi, A. Di Sarno, S. Tafuto
Journal: Annals of Oncology (2023)
1272P Postoperative survival prediction in non-small cell lung cancer patients based on driver genotypes
Authors: H. Wang, C.C. Li, J. Li, F. Li, R. Zhong, S. Xion, B. Cheng, Y. Xiang, W. Fu, K. Yu, P. Chen, X. Zheng, J. He, W. Liang
Journal: Annals of Oncology (2023)
1273P The prognostic value evaluation of a tissue Comprehensive Genomic Profiling (CGP)-informed personalized MRD detection assay in NSCLC
Authors: W. Gao, J-T. Zhang, W. Cao, S-Y. Liu, X. Zeng, Y. Gong, W-Z. Zhong, N. Fu, X. Du, Z. Qing, Y-L. Wu
Journal: Annals of Oncology (2023)
1299P The role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study
Authors: L. Chen, F. Tong, Y. Kong, R. Zhang, P. Ding, S. Zhang, Y. Wang, R. Zhou, X. Pu, B. Chen, F. Liang, Q. Tan, Y. Xu, L. Wu, X. Dong
Journal: Annals of Oncology (2023)
1592MO Anticancer therapy at the end-of-life: A cluster-randomized trial
Authors: M.J. Hjermstad, A. Pirnat, N. Aass, S. Andersen, G.L. Astrup, O. Dajani, H. Garresori, K.V. Guldhav, H.M. Hamre, E.C. Haukland, F. Jordal, E.T. Lohre, T. Lundeby, S. Mjaaland, Ø. Paulsen, K.A. Semb, E.S. Staff, T.E. Wester, S. Kaasa
Journal: Annals of Oncology (2023)
1298P Chemotherapy with concurrent proton vs. photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and immune therapy
Authors: F. Cortiula, L. Hendriks, R. Wijsman, R. Houben, M. Steens, S. Debakker, C. Reverberi, N.M. Sijtsema, A. Niezink, S. Urban, A. Michelotti, S. Dursun, G. Bootsma, D. Hattu, R. Canters, E. Moretti, V.T. Taasti, D. De Ruysscher
Journal: Annals of Oncology (2023)
1595P Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Authors: S. Buriolla, F. Pravisano, J. Costa, M. Alberti, G. Bortolus, G. Zapelloni, G. De Pieri, G. Targato, G. Pascoletti, F. Puglisi, G. Fasola, A.M.M. Minisini
Journal: Annals of Oncology (2023)
2034MO EAGER: A randomized, controlled, multicenter trial of electro-acupuncture in gastric cancer patients undergoing adjuvant chemotherapy
Authors: H-B. Zhang, Y. Zhu, J.J. Mao, X-S. Chang, J-J. Peng, X-Y. Wu, W. Wang, D-C. Diao, Y. Li, H-Y. Zhang, X-H. Zhai, J-L. Yu, W. Wang, J-X. Zhou, Z-L. Huang, T. Zhang, Y-H. Liu, R. Zhou, H-C. Ma, Y-D. Chen
Journal: Annals of Oncology (2023)
1608P Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
Authors: O. Dizdar, T.K. Sahin, Y. Ozbay, A.Y. Altunbulak, H.İ. Altunbulak, M.R. Onur, F. Ceylan, D.C. Guven, S. Yalcin
Journal: Annals of Oncology (2023)
1596P Exploring the economic impact of palliative care in oncology at the end of life
Authors: S.A. Gomes, F.S. Sorice, C.D. Bergerot, D.N.E. Silva, R.M. Peixoto, M. Costa e Silva, H.M. Oliveira, A.V. Nogueira, C.G.M. Ferreira, A. Andrade Dos Anjos Jacome, B.L. Ferrari
Journal: Annals of Oncology (2023)
1293MO Safety and efficacy of hypo- and conventionally fractionated thoracic radiotherapy plus durvalumab in elderly or frail NSCLC stage III patients unfit for chemotherapy: Interim results from the TRADE-hypo trial
Authors: F. Bozorgmehr, E.L. Buchmeier, M. Hammer-Hellmig, U. Nestle, C. Meyer zum Bueschenfelde, F. Weykamp, J. Classen, P. Schuett, T. Riedel, T. Wehler, S. Hey-Koch, T.R. Overbeck, J. Alt, H. Schmidberger, R. Behnisch, I. Chung, M. Thomas, S. Rieken
Journal: Annals of Oncology (2023)
2031O Randomized trial of a telephone-based weight loss intervention in overweight and obese patients (pts) with breast cancer (BC): The MEDEA trial
Authors: I.V. Vaz Luis, A. Di Meglio, E. Martin, L. Vanlemmens, C. Segura-Djezzar, C. Bouleuc, O. Tredan, B. Pistilli, T. Crane, D. Soldato, C. Charles, A. Barbier, B. Raynard, A. Mangin, B. Coquet, G. Jacob, J. Bonastre, S. Michiels, D. Chaltiel, J. Ligibel
Journal: Annals of Oncology (2023)
1594P End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Authors: E. Slotman, H. Fransen, H.W.M. van Laarhoven, M.H. van den Beuken-van Everdingen, V. Tjan-Heijnen, A. Huijben, A. Jager, C. van Zuijlen, E. Kuip, Y. van der Linden, N. Raijmakers, S. Siesling
Journal: Annals of Oncology (2023)
2041P The prevalence of hematologic adverse events (HAEs) and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) in patients (pts) with advanced high grade ovarian carcinoma (aHGOC) receiving PARP inhibitor (PARPi), with or without a germline BRCA pathogenic variant
Authors: C. Valenza, E. Nicolo, M. Mongillo, D. Trapani, F. Gigli, L. Boldrini, L. Boscolo Bielo, G. Castellano, L. Guidi, J. Katrini, G. Pellizzari, J. Villa, I.T. Lorenzetti, S. Derio, M.T. La Presa, G. Parma, G. Curigliano, N. Colombo
Journal: Annals of Oncology (2023)
1599P Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Authors: None Leonetti, M. Peroni, V. Agnetti, F. Pratticò, M. Manini, A. Acunzo, F. Marverti, S. Sulas, E. Rapacchi, G. Mazzaschi, F. Perrone, P. Bordi, S. Buti, M. Tiseo
Journal: Annals of Oncology (2023)
1302P Treatment outcomes and safety of durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: A real-world, multi-center observational study
Authors: P. Sitthideatphaiboon, T. Reungwetwattana, S. Jaruhathai, A. Supavavej, P. Limpawittayakul, K. Maneenil, K. Korphaisarn, T. Suksombooncharoen, L. Thongthieang, C. Sathitruangsak, C. Chayangsu, H. Ratanabunjerdkul, N. Prasongsook, V. Sriuranpong
Journal: Annals of Oncology (2023)
2033MO The impact of proton pump inhibitor (PPI) exposure before immune checkpoint inhibitor (ICI) therapy on overall survival (OS): A population-based study
Authors: L. Eng, S. Saibil, R. Sutradhar, V. Aghanya, Y. Kaliwal, Y. Niu, N. Liu, Y. Liu, M. Powis, G. Liu, J. Peppercorn, P.L. Bedard, M.K. Krzyzanowska
Journal: Annals of Oncology (2023)
1603P The ability of the LACE index to predict 30-day readmissions in oncology patients
Authors: B. Ulas Kahya, O. Yazici, O. Sutcuoglu, N. Ozdemir, N. Günel, A. Uner, G. Savaş, D. Ercan Uzundal, A. Özet
Journal: Annals of Oncology (2023)
1597P Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Authors: C. Moloney, H.K. Carroll, E. Cunningham, M. Lyons, D. Nuzum, R. Bambury, D.C. Collins, R.M. Connolly, S. Iqbal, S.A. Noonan, D.G. Power, A. Lowney, M.J. O'Leary, S. O'Reilly
Journal: Annals of Oncology (2023)
2030O Remote symptom monitoring with electronic patient-reported outcomes (ePROs) during treatment for metastatic cancer: Results from the PRO-TECT trial (Alliance AFT-39)
Authors: E. Basch, D. Schrag, J. Jansen, B. Ginos, P.A. Spears, M. Jonsson, P. Carr, A.M. Deal, G. Thanarajasingam, B.B. Reeve, C. Snyder, D. Bruner, D. Cella, V. Blinder, L. Kottschade, J. Perlmutter, C. Geoghegan, G.L. Mazza, A. Weiss, A.C. Dueck
Journal: Annals of Oncology (2023)
2043P Can Charlson Comorbidity Index (CCI) and Clinical Frailty Scale (CFS) assessments predict survival in octogenarians with colorectal cancer?
Authors: N.M. Nikolic, N.S. Stanic, F.R. Djordjevic, K. Ljujic, D. Kolovic, D. Radosavljevic, J. Spasic
Journal: Annals of Oncology (2023)
1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study)
Authors: T. Kondo, K. Kubota, S. Nakamichi, T. Misumi, S. Murakami, Y. Shiraishi, H. Imai, D. Harada, K. Isobe, H. Itani, S. Takata, H. Wakui, Y. Taniguchi, S. Ikeda, T. Asao, N. Furuya, S. Hosokawa, Y. Kobayashi, Y. Takiguchi, H. Okamoto
Journal: Annals of Oncology (2023)
1285P Lung cancer in never smokers (LCINS): Clinicopathological characteristics and treatment outcomes from a university cancer centre in London
Authors: C. Gousis, E. Josephides, H. McGrath, K. Ryanna, G. Santis, A. Bille, D. Smith, S. Ahmad, S. Ghosh, S. Gennatas, E.M. Karapanagiotou, J. Spicer, A. Georgiou
Journal: Annals of Oncology (2023)
1266P Prediction of lung cancer risk in ground-glass nodules using deep learning from CT images
Authors: A. Vachani, S. Zeb, J. Steltz, W. Hickes, M. Clarke, A. Kamara, K. Spechko, G. Padley, E. Bartlett, L. Freitag, A. Scarsbrook, S. Padley, F. Gleeson
Journal: Annals of Oncology (2023)
1195P Neuroendocrine Tumors (NETs): How Big Data (BD) techniques applied to Electronic Health Records (EHR) can improve our understanding of this patient population
Authors: J. Hernando, J. Fuster Salva, J.A. Balsa, D. Malon Gimenez, A-S. Grandoulier, C. Courteval, J. Valdivieso, J.J. Díez Gómez
Journal: Annals of Oncology (2023)
1199P MAVERIC: Phase II randomized study of everolimus as maintenance therapy for metastatic neuroendocrine neoplasms (mNEN) with pulmonary or gastroenteropancreatic (GEP) origin. Results on behalf of the GOIRC
Authors: L. Antonuzzo, S. Pillozzi, R. Marconcini, F. Spada, F. Gelsomino, V. Amoroso, F. cosso, L. messerini, F. Zepponi, F. Scolari, E. Pellegrini, C. Sparano, D. Lavacchi, M. Brugia, E. Giommoni, G. Massaro, M. Milione, F. Di Costanzo, L. Boni, N. Fazio
Journal: Annals of Oncology (2023)
1201P Evaluation of efficacy TEMCAP regiment as first-line or further line therapy in patients with advanced, unresectable, progressive GEP-NET. Real-world data
Authors: A.D. Kolasinska-Cwikla, J. Cwikla, J. Palucki, M.A. Kawecki, K. Marcisz-Grzanka, K. Roszkowska-Purska, K. Jakubowicz, E. Chrapowicki, L.S. Wyrwicz
Journal: Annals of Oncology (2023)